Dr Amandeep Singh et al JMSCR Volume 08 Issue 12 December 2020 Page 83 JMSCR Vol||08||Issue||12||Page 83-89||December 2020 Mortality among COVID-19 Patients- A Retrospective Study Authors Dr Amandeep Singh 1 , Dr Pankaj Jorwal 2* , Dr Upendra Baitha 3 , Dr Manish Soneja 4 , Dr Ashutosh Biswas, MD 5 1 Senior Resident, 2 Associate Professor, 3 Assistant Professor, 4 Additional Professor, 5 Professor Department of Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi *Corresponding Author Dr Pankaj Jorwal Abstract Objectives: Since December 2019, COVID-19 is engulfing the whole world day by day. It has a wide range of clinical manifestations which are evolving daily. We reviewed the factors associated with mortality among admitted COVID-19 patients by analysing their clinical profile and lab parameters. Methods: Case records of 50 COVID-19 cases admitted to a medicine unit at AIIMS, New Delhi from April to mid-June were analysed retrospectively after applying inclusion and exclusion criteria. The course of disease was compared among survivors and non survivors. Results: Among 50 subjects, 86% were below 60 years of age and 14% were above 60, mortality was higher in elderly age group and was statistically significant (p<0.05). Most patients were symptomatic; fever and dyspnoea being common presenting complain seen in 62% of patients followed by cough, myalgia, sore throat, diarrhoea and rash. Among patients who presented with all three symptoms at presentation (fever, cough & dyspnoea), 43% succumbed to disease. Looking at severity, 38% were mild, 42% were moderate and 20% were severe cases at admission. The mortality was highest in severe group (90%). Prior co morbidities were seen in 60% cases. Hypertension (24%) was the commonest followed by diabetes (18%) and CKD (6%). 66.7 % of patients with CKD died. Among non-survivors, 37.5% were anaemic and 72.7% had leucocytosis (p<0.05). 53.8% patients with raised urea and 36.3% patients with raised creatinine also died. Conclusion: Older age, anaemia, leucocytosis and deranged renal function at the presentation are significantly associated with mortality among admitted COVID-19 patients. Keywords: COVID-19 Disease, Risk Factors, Mortality. Introduction At the end of year 2019, an outbreak of acute respiratory infection occurred in the Wuhan province of China that has wobbled the world. The virus is from the family of corona viruses and is labelled as SARS-Cov-2, because of its high similarity to SARS-CoV, which led to epidemic in 2002-2003. The disease has been labelled as COVID-19. The virus has spread worldwide leading to declaration of pandemic by WHO on 11 th March 2020. [1] Currently by 21 August 22, 925, 540 COVID-19 Cases along with 798,237 deaths occurred in 215 countries in the world. The United States of America is having the maximum http://jmscr.igmpublication.org/home/ ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v8i12.14